Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT06295809 |
| Title | A Study of (Neo)Adjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007) |
| Acronym | (V940-007) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Gallipoli Medical Research Ltd-GMRF CTU ( Site 3206) | RECRUITING | Greenslopes | Queensland | 4120 | Australia | Details |
| One Clinical Research ( Site 3211) | RECRUITING | Nedlands | Western Australia | 6009 | Australia | Details |
| Hadassah Medical Center ( Site 2201) | RECRUITING | Jerusalem | 9112001 | Israel | Details | |
| Rabin Medical Center ( Site 2202) | RECRUITING | Petah Tikva | 4941 492 | Israel | Details |